Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

Share Price is delayed by 15 minutes
Get Live Data
0.0105    0.00 (0.00%)
Bid:
0.009
Ask:
0.012
Spread: 0.003 (33.333%)
Market Cap: £1.64m
SYN Live PriceLast checked at - London Stock Exchange

Intraday Synergia Energy Share Chart

Operational Update, Equity Issue and TVR

5 Nov 2024 07:00

RNS Number : 9661K
Synergia Energy Ltd
05 November 2024
 

RNS Announcement

 

5 November 2024

 

AIM: SYN

Operational Update, Equity Issue and TVR

 

The Board of Synergia Energy Limited (Synergia or the Company) is very pleased to announce that it has arranged funding for the initial development of its UK carbon capture and storage ("CCS") project and for general working capital requirements.

 

Operational update

 

As previously announced, the Company has completed its farm out of a 50% working interest in its Cambay PSC in India to Selan Exploration Limited ("Selan"). Selan have now commenced the agreed $20 million work program on the Cambay Field PSC, for which Synergia is to be carried by Selan. A significant increase in production and cashflow from the work program is anticipated from Q2 2025 onwards.

 

The Company's Medway Hub Camelot CCS project, (the "CCS Project"), a 50:50 joint venture with Harbour Energy, is being progressed through the NSTA-prescribed work program and solid progress is being achieved on the next (site characterisation and assessment) phases. As previously announced, Synergia are seeking to farm out up to 25% of the CCS Project.

 

Equity Issue

 

The Company has completed an equity issue of a total of 2,021,800,000 new fully paid ordinary shares (New Shares) at 0.05 pence per share pursuant to a) a capital raise of £632,500 with existing and new sophisticated and institutional investors through a placing led by Novum Securities Limited (Novum), b) the conversion of £295,740 of loans (and accrued interest) into new ordinary shares and c) through the equity settlement of £82,350 of fees owed to professional advisers.

 

The capital raise will act as a bridge to the expected increased cashflow from the Cambay PSC, and the targeted farm out of the CCS Project.

 

The abovementioned conversion of loans is in relation to the unsecured loans from existing investors announced on 12 June 2024. Subsequent to the equity settlement, there are no further outstanding loan balances.

 

Each new ordinary share issued will come with one free unquoted warrant resulting in 2,021,180,000 warrants. The warrants are exercisable at 0.1 pence per share on or before the 04 November 2026.

 

In connection with the capital raise, the Company has also agreed to issue 75,900,000 unquoted options to Novum, exercisable at 0.05 pence on or before 30 November 2029 (Fee Options).

 

Net proceeds from the capital raise are intended to be applied to the CCS project, and the Company's working capital base.

 

The New Shares will rank pari passu in all respects with the existing shares. Application will be made in due course to the London Stock Exchange for the New Shares to be admitted to trading on AIM with a further announcement at that time.

 

 

Total Voting Rights

 

Following the issue of all of the New Shares, the Company's share capital and total voting rights will comprise 12,760,055,029 shares. The Company does not hold any shares in treasury. Consequently, 12,760,055,029 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Related Party Transaction

Republic Investment Management Pte Ltd ("Republic") participated in £100,000 of the placing. Republic has a current shareholding in the Company of 15.3% and is therefore categorised as a Substantial Shareholder of the Company pursuant to the AIM Rules for Companies ("AIM Rules"). Accordingly, Republic's participation in the placing is classified as a related party transaction pursuant to the AIM Rules.

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of Republic's participation are fair and reasonable insofar as the Company's shareholders are concerned.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For and on behalf of Synergia Energy Limited

 

Roland Wessel

CEO

For further information, please contact:

Investor Enquires

Synergia Energy Ltd

Briana Stayt

Investor Relations

Email: 

bstayt@synergiaenergy.com

Tel: +61 8 9485 3200

Australia

AIM Joint Broker

Panmure Liberum Ltd

Broker

Mark Murphy / Rauf Munir / Freddie Wooding

Tel: +44 (0)20 7886 2500

UK

AIM Joint Broker

Novum Securities

Broker

Colin Rowbury

Email: 

crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Ritchie Balmer / Rory Murphy

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Consulting

Investor Relations

Patrick d'Ancona / Finlay Thomson

Email:

patrick.dancona@vigoconsulting.com

finlay.thomson@vigoconsulting.com

Tel:+ 44 20 7390 0230

UK

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKFSEADLFEA
Date   Source Headline
27th May 20267:00 amRNSCambay PSC Update
12th May 20267:00 amRNSAppointment of Non-Executive Director
5th May 20267:00 amRNSCambay PSC and Board Changes
7th Apr 20267:00 amRNS$0.7m loan agreement
26th Mar 20267:00 amRNSInterim Report for the Half-Year Ended 31 Dec 2025
6th Mar 20261:52 pmRNSCambay PSC Production Update - Correction
6th Mar 20267:00 amRNSCambay PSC Production Update
9th Feb 20261:29 pmRNSCambay PSC Sale Agreement Update
22nd Jan 20267:00 amRNSCambay PSC Update
29th Dec 202511:22 amRNSResults of General Meeting
29th Dec 202511:22 amRNSResults of General Meeting
3rd Dec 20253:40 pmRNSCambay PSC Sale FAQs / Cambay PSC Update
1st Dec 202511:15 amRNSProposed Sale, cancellation of admission, & GM
1st Dec 202510:48 amRNSResults of Annual General Meeting
1st Dec 20257:00 amRNSCambay PSC SPA Signature / Cambay PSC Update
17th Nov 20259:30 amRNSCambay PSC Update
10th Nov 20251:00 pmRNSCambay PSC Update
4th Nov 20259:44 amRNSCambay PSC Update
3rd Nov 20257:00 amRNSAGM – Notice of Meeting
29th Oct 20257:00 amRNSCambay PSC Update
20th Oct 20257:00 amRNSCambay PSC Update
7th Oct 20257:00 amRNSAudited Annual Report for Year Ended 30 June 2025
16th Sep 20257:00 amRNSCambay PSC Update
27th Aug 20257:00 amRNSCambay PSC Update
4th Aug 20257:00 amRNSCambay PSC Update
21st Jul 202510:15 amRNSTR-1 Standard form notification of major holdings
8th Jul 20257:01 amRNSCambay PSC Work Program Update
8th Jul 20257:00 amRNSCorrection - Proposed Sale of Cambay PSC
4th Jul 202511:32 amRNSProposed Sale of Cambay PSC to Selan Exploration
24th Jun 202510:08 amRNSTR-1: Standard form notification of major holdings
10th Jun 20257:00 amRNSChange of Nominated Advisor
2nd Jun 20257:53 amRNSCambay PSC Update
4th Apr 202510:11 amRNSCambay PSC Update
14th Mar 20251:50 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSInterim Financial Report
24th Feb 20257:00 amRNS£750,000 Fundraise
10th Feb 20257:00 amRNSOperations Update
4th Feb 20257:00 amRNSAppointment of Executive Director
10th Jan 20257:00 amRNSChange of Joint Broker
19th Dec 20247:00 amRNSCambay Workover Update
5th Dec 20249:45 amRNSHolding(s) in Company
28th Nov 20244:00 pmRNSMedway Hub Camelot CCS Project Update
22nd Nov 20241:01 pmRNSResults of Annual General Meeting
20th Nov 20247:00 amRNSOption Exercise, Placing Update and TVR
8th Nov 20247:00 amRNSCambay Operational Update
5th Nov 20247:00 amRNSOperational Update, Equity Issue and TVR
30th Oct 20241:00 pmRNSIssue of Options
24th Oct 20247:00 amRNSAGM - Notice of Meeting
23rd Oct 202410:37 amRNSChange of Directors
14th Oct 20247:00 amRNSCambay Work Program Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.